Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-04-15 | Mr. Joel ScalesExec. VP and MD of Jamieson International & Global Strategy | 28,00 | 698,68 | Acquisition Under Employee Benefit Plan | 24,95 | 6,77k | 0,42% |
| 2026-04-15 | Mr. Paul GalbraithExec. VP & MD of USA | 142,00 | 3,54k | Acquisition Under Employee Benefit Plan | 24,95 | 5,84k | 2,49% |
| 2026-04-15 | Mr. Don BirdInitié | 169,00 | 4,22k | Acquisition Under Employee Benefit Plan | 24,95 | 20,60k | 0,83% |
| 2026-03-13 | Mr. John DohertyChief Science & Innovation Officer | 9,42k | 239,95k | Achat | 25,47 | 20,48k | 85,16% |
| 2026-03-10 | Ms. Diane NyisztorIndependent Director | 1,76k | 45,97k | Derivative Exercise and Retained Stock | 26,13 | 1,25k | -345,58% |
| 2026-03-10 | Ms. Diane NyisztorIndependent Director | -509,00 | 13,30k | Vente | 26,13 | 1,25k | -28,94% |
| 2026-03-10 | Dr. Louis J. AronneMember of the Scientific Advisory Board & Director | 2,11k | 55,16k | Derivative Exercise and Retained Stock | 26,13 | 11,48k | 22,54% |
| 2026-03-10 | Dr. Louis J. AronneMember of the Scientific Advisory Board & Director | -633,00 | 16,54k | Vente | 26,13 | 11,48k | -5,23% |
| 2026-03-09 | Mr. Christopher SnowdenCFO | 29,21k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 26,89 | 169,32k | 20,85% |
| 2026-03-09 | Ms. Regan StewartCOO | 26,64k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 26,89 | 209,27k | 14,58% |
| 2026-03-09 | Mr. Michael PilatoPresident, CEO & Director | 86,38k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 26,89 | 565,60k | 18,02% |
| 2026-03-09 | Mr. John DohertyChief Science & Innovation Officer | 36,87k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 26,89 | 223,38k | 19,77% |
| 2026-03-09 | Mr. Paul GalbraithExec. VP & MD of USA | 15,45k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 26,89 | 95,16k | 19,38% |
| 2026-03-09 | Mr. Joel ScalesExec. VP and MD of Jamieson International & Global Strategy | 15,13k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 26,89 | 91,48k | 19,82% |
| 2026-03-09 | Mr. Eric BentzExec. VP of Global Marketing & MD of Canada | 15,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 26,89 | 67,16k | 28,76% |
| 2026-03-05 | Mr. Christopher SnowdenCFO | -18,38k | 5,07k | Derivative Exercise and Sale | 25,84 - 26,12 | 172,02k | - |
| 2026-03-05 | Ms. Regan StewartCOO | 18,38k | 474,88k | Derivative Exercise and Retained Stock | 25,84 | 35,41k | 107,90% |
| 2026-03-09 | Ms. Regan StewartCOO | -9,84k | 256,92k | Vente | 26,12 | 35,41k | -21,74% |
| 2026-03-05 | Mr. John DohertyChief Science & Innovation Officer | -14,12k | 3,90k | Derivative Exercise and Sale | 25,84 - 26,12 | 15,77k | - |
| 2026-03-05 | Mr. Don BirdInitié | -14,12k | 3,90k | Derivative Exercise and Sale | 25,84 - 26,12 | 20,43k | - |
| 2026-03-05 | Mr. Paul GalbraithExec. VP & MD of USA | -10,08k | 2,78k | Derivative Exercise and Sale | 25,84 - 26,12 | 5,69k | - |
| 2026-03-05 | Mr. Joel ScalesExec. VP and MD of Jamieson International & Global Strategy | -11,59k | 3,20k | Derivative Exercise and Sale | 25,84 - 26,12 | 6,74k | - |
| 2026-03-05 | Mr. Eric BentzExec. VP of Global Marketing & MD of Canada | 4,37k | 112,99k | Derivative Exercise and Retained Stock | 25,84 | 5,13k | 577,54% |
| 2026-03-05 | Mr. Eric BentzExec. VP of Global Marketing & MD of Canada | -5,04k | 1,39k | Derivative Exercise and Sale | 25,84 - 26,12 | 5,13k | - |
| 2026-03-05 | Mr. Michael PilatoPresident, CEO & Director | 24,61k | 636,04k | Derivative Exercise and Retained Stock | 25,84 | 82,35k | 42,62% |
| 2026-03-05 | Mr. Michael PilatoPresident, CEO & Director | -28,35k | 7,83k | Derivative Exercise and Sale | 25,84 - 26,12 | 82,35k | - |
| 2026-01-15 | Mr. Don BirdInitié | 197,00 | 4,88k | Acquisition Under Employee Benefit Plan | 24,77 | 20,43k | 0,97% |
| 2026-01-15 | Mr. Paul GalbraithExec. VP & MD of USA | 165,00 | 4,09k | Acquisition Under Employee Benefit Plan | 24,77 | 5,69k | 2,98% |
| 2026-01-15 | Mr. Joel ScalesExec. VP and MD of Jamieson International & Global Strategy | 32,00 | 792,77 | Acquisition Under Employee Benefit Plan | 24,77 | 6,74k | 0,48% |
| 2025-10-15 | Mr. Don BirdInitié | 195,00 | 4,83k | Acquisition Under Employee Benefit Plan | 24,76 | 20,24k | 0,97% |
| 2025-10-15 | Mr. Paul GalbraithExec. VP & MD of USA | 163,00 | 4,04k | Acquisition Under Employee Benefit Plan | 24,76 | 5,53k | 3,04% |
| 2025-10-15 | Mr. Joel ScalesExec. VP and MD of Jamieson International & Global Strategy | 32,00 | 792,38 | Acquisition Under Employee Benefit Plan | 24,76 | 6,71k | 0,48% |
| 2025-09-11 | Ms. Regan StewartCOO | -12,20k | 187,46k | Derivative Exercise and Sale | 11,38 - 26,75 | 26,87k | - |
| 2025-09-15 | Mr. Michael PilatoPresident, CEO & Director | -24,08k | 196,25k | Derivative Exercise and Sale | 18,65 - 26,80 | 57,74k | - |
| 2025-09-05 | Ms. Regan StewartCOO | -9,10k | 140,22k | Derivative Exercise and Sale | 11,39 - 26,80 | 26,87k | - |
| 2025-08-12 | Mr. Christopher SnowdenCFO | 122,05k | 1,85M | Derivative Exercise and Retained Stock | 11,45 - 18,90 | 172,02k | 244,24% |
| 2025-08-19 | Mr. Christopher SnowdenCFO | -106,85k | 2,78M | Vente | 26,01 | 172,02k | -38,32% |
| 2025-08-26 | Mr. Paul GalbraithExec. VP & MD of USA | -7,91k | 61,44k | Derivative Exercise and Sale | 18,62 - 26,40 | 5,37k | - |
| 2025-08-19 | Ms. Regan StewartCOO | -12,50k | 184,78k | Derivative Exercise and Sale | 11,36 - 26,29 | 26,87k | - |
| 2025-08-20 | Mr. Joel ScalesExec. VP and MD of Jamieson International & Global Strategy | -6,49k | 50,07k | Derivative Exercise and Sale | 18,58 - 26,29 | 6,68k | - |
| 2025-08-12 | Mr. John DohertyChief Science & Innovation Officer | -25,44k | 207,61k | Derivative Exercise and Sale | 18,72 - 26,88 | 15,77k | - |
| 2025-08-13 | Mr. Don BirdInitié | -27,13k | 224,38k | Derivative Exercise and Sale | 18,70 - 26,97 | 20,04k | - |
| 2025-07-15 | Mr. Don BirdInitié | 166,00 | 4,24k | Acquisition Under Employee Benefit Plan | 25,53 | 20,04k | 0,84% |
| 2025-07-15 | Mr. Paul GalbraithExec. VP & MD of USA | 139,00 | 3,55k | Acquisition Under Employee Benefit Plan | 25,53 | 5,37k | 2,66% |
| 2025-07-15 | Mr. Joel ScalesExec. VP and MD of Jamieson International & Global Strategy | 27,00 | 689,43 | Acquisition Under Employee Benefit Plan | 25,53 | 6,68k | 0,41% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
